Search

Search Constraints

You searched for: Author/Creator Kiefer, James R.

Search Results

1. Design and evaluation of 1, 7-naphthyridones as novel KDM5 inhibitors. Issue 18 (15th September 2016)

2. Design and evaluation of 1, 7-naphthyridones as novel KDM5 inhibitors. Issue 18 (15th September 2016)

3. Discovery of a C-8 hydroxychromene as a potent degrader of estrogen receptor alpha with improved rat oral exposure over GDC-0927. Issue 16 (15th August 2019)

4. Discovery of GNE-502 as an orally bioavailable and potent degrader for estrogen receptor positive breast cancer. (15th October 2021)

5. From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors. Issue 13 (1st July 2017)

6. Inhibition of bromodomain-containing protein 9 for the prevention of epigenetically-defined drug resistance. Issue 15 (1st August 2017)

7. Lead optimization of a pyrazolo[1, 5-a]pyrimidin-7(4H)-one scaffold to identify potent, selective and orally bioavailable KDM5 inhibitors suitable for in vivo biological studies. Issue 16 (15th August 2016)

9. Target 2035 – update on the quest for a probe for every protein. Issue 1 (3rd December 2021)

10. Unexpected equivalent potency of a constrained chromene enantiomeric pair rationalized by co-crystal structures in complex with estrogen receptor alpha. Issue 7 (1st April 2019)